Skip to main content
. 2021 Mar 6;16(4):1222–1232. doi: 10.1016/j.jds.2020.11.015

Table 2.

Overall parameters for primary, secondary and non-Sjögren's syndrome patients.

Studies study groups n PPD (mm) statistical association (compared to control) statistical association (SSS compared to PSS)
Antoniazzi et al.10 PSS 11 2.23 ± 0.09 (SE) p > 0.05
SSS 8 2.62 ± 0.16 (SE) p < 0.05 p < 0.05
control 19 2.10 ± 0.10 (SE)
Ergun et al.11 mix-SS 37 1.88 ± 0.41 (SEM) NS
control 37 1.95 ± 0.63 (SEM)
Kuru et al.22 PSS 8 1.78 ± 0.39 (SD) NS
SSS 10 2.04 ± 0.53 (SD) NS NS
control 11 2.04 ± 0.33 (SD)
Marton et al.23 PSS 38 2.28 ± 1.09 (SD) p < 0.05
control 34 1.82 ± 0.73 (SD)
Najera et al.24 mix-SS 25 1.92 ± 0.38 (SD) NS
control 24 1.80 ± 0.27 (SD)
Pedersen et al.16 PSS 16 2.32 ± 0.71 (SD) NS
control 14 2.71 ± 0.99 (SD)
Pedersen et al.15 PSS 20 2.36 ± 1.01 (SD) NS
control 20 2.37 ± 1.01 (SD)
Rhodus & Michalowicz12 PSS 10 3.49 ± 0.51 (SE) NS
control 10 3.02 ± 0.31 (SE)
Tseng25 mix-SS 14 3.02 ± 0.31 (SD) NS
control 14 2.82 ± 0.36 (SD)
Studies study groups n CAL (mm) statistical association (compared to control) statistical association (SSS compared to PSS)
Antoniazzi et al.10 PSS 11 2.57 ± 0.20 (SE) NS
SSS 8 3.67 ± 0.50 (SE) p < 0.05 p < 0.05
control 19 2.40 ± 0.14 (SE)
Kuru et al.22 PSS 8 2.14 ± 0.65 (SD) NS
SSS 10 2.76 ± 1.79 (SD) NS NS
control 11 2.60 ± 0.77 (SD)
Najera et al.24 mix-SS 25 2.20 ± 0.48 (SD) p < 0.05
control 24 1.96 ± 0.31 (SD)
Rhodus & Michalowicz12 PSS 10 5.44 ± 0.39 (SE) p < 0.10
control 10 2.70 ± 0.80 (SE)
Tseng25 mix-SS 14 2.70 ± 0.80 (SD) NS
control 14 2.79 ± 0.46 (SD)
Studies study groups n PI statistical association (compared to control) statistical association (SSS compared to PSS)
Antoniazzi et al.10 Antoniazzi et al.14 Antoniazzi et al.14 Antoniazzi et al.14 Antoniazzi et al.14 Antoniazzi et al.14
SSS 8 1.28 ± 0.10 (SE) p < 0.05 p < 0.05
control 19 0.73 ± 0.06 (SE)
Kuru et al.22 PSS 8 1.18 ± 0.33 (SD) NS
SSS 10 1.44 ± 0.33 (SD) NS NS
control 11 1.44 ± 0.56 (SD)
Najera et al.24 mix-SS 25 0.96 ± 0.42 (SD) p < 0.05
control 24 0.65 ± 0.24 (SD)
Pedersen et al.16 PSS 16 0.54 ± 0.31 (SD) NS
control 14 0.52 ± 0.18 (SD)
Pedersen et al.15 PSS 20 0.61 ± 0.70 (SD) NS
control 20 0.60 ± 0.71 (SD)
Rhodus & Michalowicz12 PSS 10 0.97 ± 0.46 (SE) p < 0.10
control 10 0.65 ± 0.35 (SE)
Tseng25 mix-SS 14 0.5 ± 0.35 (SD) NS
control 14 0.32 ± 0.28 (SD)
Studies study groups n GI statistical association (compared to control) statistical association (SSS compared to PSS)
Antoniazzi et al.10 PSS 11 1.15 ± 0.07 (SE) p < 0.05
SSS 8 1.19 ± 0.07 (SE) p < 0.05 p > 0.05
control 19 0.71 ± 0.05 (SE)
Kuru et al.22 PSS 8 1.47 ± 0.32 (SD) NS
SSS 10 1.47 ± 0.32 (SD) NS NS
control 11 1.52 ± 0.65 (SD)
Najera et al.24 mix-SS 25 1.11 ± 0.49 (SD) NS
control 24 1.01 ± 0.33 (SD)
Pedersen et al.16 PSS 16 0.49 ± 0.31 (SD) NS
control 14 0.48 ± 0.30 (SD)
Pedersen et al.15 PSS 20 0.32 ± 0.56 (SD) NS
control 20 0.34 ± 0.60 (SD)
Rhodus & Michalowicz12 PSS 10 1.37 ± 0.66 (SE) NS
control 10 0.98 ± 0.36 (SE)
Tseng25 mix-SS 14 0.98 ± 0.36 (SD) NS
control 14 0.79 ± 0.28 (SD)

PSS, primary Sjogren's syndrome SS; SSS, secondary Sjogren's syndrome; mix-SS, primary Sjogren's syndrome and secondary Sjogren's syndrome; PPD, periodontal probing depth; CAL, clinical attachment loss; PI, plaque index; GI, gingival index; SE, standard error of the mean; SD, standard deviation; NS, not significant.